Epirubicin and docetaxel as neoadjuvant treatment of locally advanced breast cancer: a phase II study

被引：0
|
作者：
Lombardi, D. [1 ]
Scalone, S. [1 ]
Crivellari, D. [1 ]
La Mura, N. [1 ]
Miolo, G. [1 ]
Murrone, A. [1 ]
Perin, T. [1 ]
Coran, F. [1 ]
Candiani, E. [1 ]
Massarut, S. [1 ]
Veronesi, A. [1 ]
机构：
[1] Ctr Riferimento Oncol, I-33081 Aviano, Italy
来源：
BREAST CANCER RESEARCH AND TREATMENT | 2007年 / 106卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：S229 / S229
页数：1
相关论文
共 50 条
  • [31] Phase I study of docetaxel and epirubicin in advanced breast cancer
    Panagos, G
    Mavroudis, D
    Potamianou, A
    Malamos, N
    Kourousis, C
    Kakolyris, S
    Souglakos, J
    Sarra, E
    Giannakakis, T
    Georgoulias, V
    [J]. ANNALS OF ONCOLOGY, 1998, 9 : 21 - 21
  • [32] A different yet traditional approach to neoadjuvant treatment of breast cancer: The combination of epirubicin and docetaxel Neoadjuvant epirubicin docetaxel in breast cancer'
    Yuce, Elif
    Karakullukcu, Serdar
    Alandag, Celal
    Bulbul, Hatice
    Saygin, Ismail
    Kavgaci, Halil
    [J]. ANNALS OF CLINICAL AND ANALYTICAL MEDICINE, 2023, 14
  • [33] Clinical outcome and predictive factors for docetaxel and epirubicin neoadjuvant chemotherapy of locally advanced breast cancer
    Won, Hye Sung
    Kim, Yong Seok
    Kim, Jeong Soo
    Chang, Eun Deok
    Na, Sae Jung
    Whang, In Yong
    Lee, Dong Soo
    [J]. KOREAN JOURNAL OF INTERNAL MEDICINE, 2020, 35 (06): : 1489 - 1496
  • [34] A Multicenter Phase II Trial of Neoadjuvant Chemotherapy with Docetaxel and Gemcitabine in Locally Advanced Breast Cancer
    Jeon, Ye Won
    Kim, Tae Hyun
    Youn, Hyun Jo
    Han, Sehwan
    Jung, Yongsik
    Gwak, Geumhee
    Park, Young Sam
    Kim, Jeong Soo
    Suh, Young Jin
    [J]. JOURNAL OF BREAST CANCER, 2017, 20 (04) : 340 - 346
  • [35] Gemcitabine combined with epirubicin in the treatment of patients with locally advanced or metastatic breast cancer -: A phase II study
    Hausmaninger, H
    Morack, G
    Heinrich, B
    Wallwiener, D
    Höffken, K
    Buksmaui, S
    Krejcy, K
    Miller, MA
    Possinger, K
    [J]. AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 2004, 27 (04): : 429 - 435
  • [36] Neoadjuvant gemcitabine, epirubicin, and docetaxel (GET). Preliminary results from a multicenter phase II trial in inflammatory and locally advanced breast cancer.
    Yardley, DA
    Whitworth, P
    Greco, FA
    Burris, HA
    White, M
    Thomas, M
    Dunbar, L
    Yost, K
    Hainsworth, JD
    [J]. BREAST CANCER RESEARCH AND TREATMENT, 2003, 82 : S54 - S54
  • [37] Neoadjuvant treatment with paclitaxel and epirubicin in invasive breast cancer: a phase II study
    Ron, IG
    Sarid, DL
    Wigler, N
    Inbar, MJ
    [J]. INTERNATIONAL JOURNAL OF CANCER, 2002, : 199 - 199
  • [38] Neoadjuvant treatment with paclitaxel and epirubicin in invasive breast cancer - A phase II study
    Sarid, David
    Ron, Ilan G.
    Sperber, Fani
    Stadler, Yona
    Kahan, Perry
    Kovner, Felix
    Ben-Yosef, Rami
    Marmor, Sylvia
    Grinberg, Yulia
    Maimon, Natalie
    Weinstein, Juliana
    Yaal-Hahoshen, Neora
    [J]. CLINICAL DRUG INVESTIGATION, 2006, 26 (12) : 691 - 701
  • [39] Epirubicin and Docetaxel as Primary Chemotherapy in Locally Advanced Breast Cancer
    Conti, F.
    Corsetti, S.
    Viola, G.
    Sperduti, I.
    Carpano, S.
    Pizzuti, L.
    Foggi, P.
    Perri, P.
    Anza, M.
    Toglia, G.
    Lopez, M.
    [J]. ONCOLOGY, 2009, 77 : 139 - 140
  • [40] ACTIVITY AND SAFETY OF A COMBINATION OF EPIRUBICIN, DOCETAXEL AND CISPLATIN AS NEOADJUVANT TREATMENT FOR LOCALLY ADVANCED BREAST CANCER (LABC): A PRELIMINARY REPORT
    Avci, N.
    Kanat, O.
    Gokgoz, S.
    Tolunay, S.
    Topal, U.
    Cubukcu, E.
    Olmez, F.
    [J]. ANNALS OF ONCOLOGY, 2012, 23 : 129 - 129
12345